Product Information
TADALAFIL 2.5 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1170 per EA under NDC 75834024730. Its NADAC has been published 215 times since Jan 27, 2021.
Strength
2.5 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834024730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA211298On Market Since
11/2/2020
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 2.5 MG TABLET has been published 215 times since Jan 27, 2021, and over the history we have for it it has declined 39.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1170 per EA |
|---|---|
| All-time high | $0.2819 (Mar 10, 2021) |
| All-time low | $0.0828 (Jul 17, 2024) |
| Median price | $0.1692 |
| Average price | $0.1697 |
| Largest weekly change | +53.6% (Aug 21, 2024) |
| Weeks tracked | 215 |
| Tracking since | Jan 27, 2021 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TADALAFIL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 2.5 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1170 per EA (NDC 75834024730), effective Mar 5, 2025.
How has the price of TADALAFIL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 2.5 MG TABLET has declined 39.6%. It has been tracked across 215 weekly CMS publications since Jan 27, 2021.
What are the highest and lowest recorded NADAC prices for TADALAFIL 2.5 MG TABLET?
Since Jan 27, 2021, the NADAC for TADALAFIL 2.5 MG TABLET has ranged from a low of $0.0828 (Jul 17, 2024) to a high of $0.2819 (Mar 10, 2021), with a median of $0.1692 per EA.
Are there cheaper alternatives to TADALAFIL 2.5 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TADALAFIL 2.5 MG TABLET, is $0.1124 per EA — about 4% below TADALAFIL 2.5 MG TABLET.
Who manufactures TADALAFIL 2.5 MG TABLET?
TADALAFIL 2.5 MG TABLET (NDC 75834024730) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification